Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial
- 1 November 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (9) , 976-980
- https://doi.org/10.1016/s0002-9149(99)00483-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Abciximab Facilitates the Rate and Extent of ThrombolysisCirculation, 1999
- Relationship Between TIMI Frame Count and Clinical Outcomes After Thrombolytic AdministrationCirculation, 1999
- α-Adrenergic Blockade Improves Recovery of Myocardial Perfusion and Function After Coronary Stenting in Patients With Acute Myocardial InfarctionCirculation, 1999
- Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarctionHeart, 1999
- TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial InfarctionCirculation, 1998
- Abnormal Coronary Flow in Infarct Arteries 1 Year After Myocardial Infarction Is Predicted at 4 Weeks by Corrected Thrombolysis in Myocardial Infarction (TIMI) Frame Count and Stenosis SeverityThe American Journal of Cardiology, 1998
- TNK-Tissue Plasminogen Activator in Acute Myocardial InfarctionCirculation, 1997
- Techniques in the Angiographic Analysis of Coronary Flow: Past, Present, and FutureJournal of Interventional Cardiology, 1996
- TIMI Frame CountCirculation, 1996
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989